Biologics Market, Global Outlook and Forecast 2023-2029

Publisher Name :
Date: 03-Feb-2023
No. of pages: 75

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.

This report aims to provide a comprehensive presentation of the global market for Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics. This report contains market size and forecasts of Biologics in global, including the following market information:

Global Biologics Market Revenue, 2018-2023, 2024-2029, ($ millions)

Global Biologics Market Sales, 2018-2023, 2024-2029, (K MT)

Global top five Biologics companies in 2022 (%)

The global Biologics market was valued at US$ 107170 million in 2022 and is projected to reach US$ 150730 million by 2029, at a CAGR of 5.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biologics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biologics Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)

Global Biologics Market Segment Percentages, by Type, 2022 (%)

- Monoclonal Antibodies

- Vaccines

- Recombinant Proteins

- Antisense

- RNAi

Global Biologics Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)

Global Biologics Market Segment Percentages, by Application, 2022 (%)

- Infectious Diseases

- Oncology

- Immunology

- Autoimmune Diseases

Global Biologics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)

Global Biologics Market Segment Percentages, By Region and Country, 2022 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biologics revenues in global market, 2018-2023 (Estimated), ($ millions)

Key companies Biologics revenues share in global market, 2022 (%)

Key companies Biologics sales in global market, 2018-2023 (Estimated), (K MT)

Key companies Biologics sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Eli Lilly & Company

- Samsung Biologics

- F Hoffman La Roche

- Celltrion

- Addgene

- Amgen

- Abbvie Inc.

- Sanofi

- Pfizer Inc.

- Merck & Co. Inc.

- Novo Nordisk A/S

- Johnson & Johnson Services Inc.

Outline of Major Chapters:

Chapter 1: Introduces the definition of Biologics, market overview.

Chapter 2: Global Biologics market size in revenue and volume.

Chapter 3: Detailed analysis of Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global Biologics capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.

Biologics Market, Global Outlook and Forecast 2023-2029

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biologics Overall Market Size
2.1 Global Biologics Market Size: 2022 VS 2029
2.2 Global Biologics Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biologics Sales: 2018-2029
3 Company Landscape
3.1 Top Biologics Players in Global Market
3.2 Top Global Biologics Companies Ranked by Revenue
3.3 Global Biologics Revenue by Companies
3.4 Global Biologics Sales by Companies
3.5 Global Biologics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biologics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biologics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biologics Players in Global Market
3.8.1 List of Global Tier 1 Biologics Companies
3.8.2 List of Global Tier 2 and Tier 3 Biologics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biologics Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Vaccines
4.1.4 Recombinant Proteins
4.1.5 Antisense
4.1.6 RNAi
4.2 By Type - Global Biologics Revenue & Forecasts
4.2.1 By Type - Global Biologics Revenue, 2018-2023
4.2.2 By Type - Global Biologics Revenue, 2024-2029
4.2.3 By Type - Global Biologics Revenue Market Share, 2018-2029
4.3 By Type - Global Biologics Sales & Forecasts
4.3.1 By Type - Global Biologics Sales, 2018-2023
4.3.2 By Type - Global Biologics Sales, 2024-2029
4.3.3 By Type - Global Biologics Sales Market Share, 2018-2029
4.4 By Type - Global Biologics Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biologics Market Size, 2022 & 2029
5.1.2 Infectious Diseases
5.1.3 Oncology
5.1.4 Immunology
5.1.5 Autoimmune Diseases
5.2 By Application - Global Biologics Revenue & Forecasts
5.2.1 By Application - Global Biologics Revenue, 2018-2023
5.2.2 By Application - Global Biologics Revenue, 2024-2029
5.2.3 By Application - Global Biologics Revenue Market Share, 2018-2029
5.3 By Application - Global Biologics Sales & Forecasts
5.3.1 By Application - Global Biologics Sales, 2018-2023
5.3.2 By Application - Global Biologics Sales, 2024-2029
5.3.3 By Application - Global Biologics Sales Market Share, 2018-2029
5.4 By Application - Global Biologics Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Biologics Market Size, 2022 & 2029
6.2 By Region - Global Biologics Revenue & Forecasts
6.2.1 By Region - Global Biologics Revenue, 2018-2023
6.2.2 By Region - Global Biologics Revenue, 2024-2029
6.2.3 By Region - Global Biologics Revenue Market Share, 2018-2029
6.3 By Region - Global Biologics Sales & Forecasts
6.3.1 By Region - Global Biologics Sales, 2018-2023
6.3.2 By Region - Global Biologics Sales, 2024-2029
6.3.3 By Region - Global Biologics Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Biologics Revenue, 2018-2029
6.4.2 By Country - North America Biologics Sales, 2018-2029
6.4.3 US Biologics Market Size, 2018-2029
6.4.4 Canada Biologics Market Size, 2018-2029
6.4.5 Mexico Biologics Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Biologics Revenue, 2018-2029
6.5.2 By Country - Europe Biologics Sales, 2018-2029
6.5.3 Germany Biologics Market Size, 2018-2029
6.5.4 France Biologics Market Size, 2018-2029
6.5.5 U.K. Biologics Market Size, 2018-2029
6.5.6 Italy Biologics Market Size, 2018-2029
6.5.7 Russia Biologics Market Size, 2018-2029
6.5.8 Nordic Countries Biologics Market Size, 2018-2029
6.5.9 Benelux Biologics Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Biologics Revenue, 2018-2029
6.6.2 By Region - Asia Biologics Sales, 2018-2029
6.6.3 China Biologics Market Size, 2018-2029
6.6.4 Japan Biologics Market Size, 2018-2029
6.6.5 South Korea Biologics Market Size, 2018-2029
6.6.6 Southeast Asia Biologics Market Size, 2018-2029
6.6.7 India Biologics Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Biologics Revenue, 2018-2029
6.7.2 By Country - South America Biologics Sales, 2018-2029
6.7.3 Brazil Biologics Market Size, 2018-2029
6.7.4 Argentina Biologics Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biologics Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Biologics Sales, 2018-2029
6.8.3 Turkey Biologics Market Size, 2018-2029
6.8.4 Israel Biologics Market Size, 2018-2029
6.8.5 Saudi Arabia Biologics Market Size, 2018-2029
6.8.6 UAE Biologics Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Eli Lilly & Company
7.1.1 Eli Lilly & Company Company Summary
7.1.2 Eli Lilly & Company Business Overview
7.1.3 Eli Lilly & Company Biologics Major Product Offerings
7.1.4 Eli Lilly & Company Biologics Sales and Revenue in Global (2018-2023)
7.1.5 Eli Lilly & Company Key News & Latest Developments
7.2 Samsung Biologics
7.2.1 Samsung Biologics Company Summary
7.2.2 Samsung Biologics Business Overview
7.2.3 Samsung Biologics Biologics Major Product Offerings
7.2.4 Samsung Biologics Biologics Sales and Revenue in Global (2018-2023)
7.2.5 Samsung Biologics Key News & Latest Developments
7.3 F Hoffman La Roche
7.3.1 F Hoffman La Roche Company Summary
7.3.2 F Hoffman La Roche Business Overview
7.3.3 F Hoffman La Roche Biologics Major Product Offerings
7.3.4 F Hoffman La Roche Biologics Sales and Revenue in Global (2018-2023)
7.3.5 F Hoffman La Roche Key News & Latest Developments
7.4 Celltrion
7.4.1 Celltrion Company Summary
7.4.2 Celltrion Business Overview
7.4.3 Celltrion Biologics Major Product Offerings
7.4.4 Celltrion Biologics Sales and Revenue in Global (2018-2023)
7.4.5 Celltrion Key News & Latest Developments
7.5 Addgene
7.5.1 Addgene Company Summary
7.5.2 Addgene Business Overview
7.5.3 Addgene Biologics Major Product Offerings
7.5.4 Addgene Biologics Sales and Revenue in Global (2018-2023)
7.5.5 Addgene Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Biologics Major Product Offerings
7.6.4 Amgen Biologics Sales and Revenue in Global (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Abbvie Inc.
7.7.1 Abbvie Inc. Company Summary
7.7.2 Abbvie Inc. Business Overview
7.7.3 Abbvie Inc. Biologics Major Product Offerings
7.7.4 Abbvie Inc. Biologics Sales and Revenue in Global (2018-2023)
7.7.5 Abbvie Inc. Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Biologics Major Product Offerings
7.8.4 Sanofi Biologics Sales and Revenue in Global (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Company Summary
7.9.2 Pfizer Inc. Business Overview
7.9.3 Pfizer Inc. Biologics Major Product Offerings
7.9.4 Pfizer Inc. Biologics Sales and Revenue in Global (2018-2023)
7.9.5 Pfizer Inc. Key News & Latest Developments
7.10 Merck & Co. Inc.
7.10.1 Merck & Co. Inc. Company Summary
7.10.2 Merck & Co. Inc. Business Overview
7.10.3 Merck & Co. Inc. Biologics Major Product Offerings
7.10.4 Merck & Co. Inc. Biologics Sales and Revenue in Global (2018-2023)
7.10.5 Merck & Co. Inc. Key News & Latest Developments
7.11 Novo Nordisk A/S
7.11.1 Novo Nordisk A/S Company Summary
7.11.2 Novo Nordisk A/S Biologics Business Overview
7.11.3 Novo Nordisk A/S Biologics Major Product Offerings
7.11.4 Novo Nordisk A/S Biologics Sales and Revenue in Global (2018-2023)
7.11.5 Novo Nordisk A/S Key News & Latest Developments
7.12 Johnson & Johnson Services Inc.
7.12.1 Johnson & Johnson Services Inc. Company Summary
7.12.2 Johnson & Johnson Services Inc. Biologics Business Overview
7.12.3 Johnson & Johnson Services Inc. Biologics Major Product Offerings
7.12.4 Johnson & Johnson Services Inc. Biologics Sales and Revenue in Global (2018-2023)
7.12.5 Johnson & Johnson Services Inc. Key News & Latest Developments
8 Global Biologics Production Capacity, Analysis
8.1 Global Biologics Production Capacity, 2018-2029
8.2 Biologics Production Capacity of Key Manufacturers in Global Market
8.3 Global Biologics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biologics Supply Chain Analysis
10.1 Biologics Industry Value Chain
10.2 Biologics Upstream Market
10.3 Biologics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biologics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Biologics in Global Market
Table 2. Top Biologics Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Biologics Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Biologics Revenue Share by Companies, 2018-2023
Table 5. Global Biologics Sales by Companies, (K MT), 2018-2023
Table 6. Global Biologics Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Biologics Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Biologics Product Type
Table 9. List of Global Tier 1 Biologics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biologics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Biologics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Biologics Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Biologics Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Biologics Sales (K MT), 2018-2023
Table 15. By Type - Global Biologics Sales (K MT), 2024-2029
Table 16. By Application - Global Biologics Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Biologics Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Biologics Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Biologics Sales (K MT), 2018-2023
Table 20. By Application - Global Biologics Sales (K MT), 2024-2029
Table 21. By Region - Global Biologics Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Biologics Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Biologics Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Biologics Sales (K MT), 2018-2023
Table 25. By Region - Global Biologics Sales (K MT), 2024-2029
Table 26. By Country - North America Biologics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Biologics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Biologics Sales, (K MT), 2018-2023
Table 29. By Country - North America Biologics Sales, (K MT), 2024-2029
Table 30. By Country - Europe Biologics Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Biologics Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Biologics Sales, (K MT), 2018-2023
Table 33. By Country - Europe Biologics Sales, (K MT), 2024-2029
Table 34. By Region - Asia Biologics Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Biologics Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Biologics Sales, (K MT), 2018-2023
Table 37. By Region - Asia Biologics Sales, (K MT), 2024-2029
Table 38. By Country - South America Biologics Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Biologics Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Biologics Sales, (K MT), 2018-2023
Table 41. By Country - South America Biologics Sales, (K MT), 2024-2029
Table 42. By Country - Middle East & Africa Biologics Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Biologics Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Biologics Sales, (K MT), 2018-2023
Table 45. By Country - Middle East & Africa Biologics Sales, (K MT), 2024-2029
Table 46. Eli Lilly & Company Company Summary
Table 47. Eli Lilly & Company Biologics Product Offerings
Table 48. Eli Lilly & Company Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. Eli Lilly & Company Key News & Latest Developments
Table 50. Samsung Biologics Company Summary
Table 51. Samsung Biologics Biologics Product Offerings
Table 52. Samsung Biologics Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. Samsung Biologics Key News & Latest Developments
Table 54. F Hoffman La Roche Company Summary
Table 55. F Hoffman La Roche Biologics Product Offerings
Table 56. F Hoffman La Roche Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 57. F Hoffman La Roche Key News & Latest Developments
Table 58. Celltrion Company Summary
Table 59. Celltrion Biologics Product Offerings
Table 60. Celltrion Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 61. Celltrion Key News & Latest Developments
Table 62. Addgene Company Summary
Table 63. Addgene Biologics Product Offerings
Table 64. Addgene Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 65. Addgene Key News & Latest Developments
Table 66. Amgen Company Summary
Table 67. Amgen Biologics Product Offerings
Table 68. Amgen Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 69. Amgen Key News & Latest Developments
Table 70. Abbvie Inc. Company Summary
Table 71. Abbvie Inc. Biologics Product Offerings
Table 72. Abbvie Inc. Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 73. Abbvie Inc. Key News & Latest Developments
Table 74. Sanofi Company Summary
Table 75. Sanofi Biologics Product Offerings
Table 76. Sanofi Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 77. Sanofi Key News & Latest Developments
Table 78. Pfizer Inc. Company Summary
Table 79. Pfizer Inc. Biologics Product Offerings
Table 80. Pfizer Inc. Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 81. Pfizer Inc. Key News & Latest Developments
Table 82. Merck & Co. Inc. Company Summary
Table 83. Merck & Co. Inc. Biologics Product Offerings
Table 84. Merck & Co. Inc. Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 85. Merck & Co. Inc. Key News & Latest Developments
Table 86. Novo Nordisk A/S Company Summary
Table 87. Novo Nordisk A/S Biologics Product Offerings
Table 88. Novo Nordisk A/S Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 89. Novo Nordisk A/S Key News & Latest Developments
Table 90. Johnson & Johnson Services Inc. Company Summary
Table 91. Johnson & Johnson Services Inc. Biologics Product Offerings
Table 92. Johnson & Johnson Services Inc. Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 93. Johnson & Johnson Services Inc. Key News & Latest Developments
Table 94. Biologics Production Capacity (K MT) of Key Manufacturers in Global Market, 2021-2023 (K MT)
Table 95. Global Biologics Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Biologics Production by Region, 2018-2023 (K MT)
Table 97. Global Biologics Production by Region, 2024-2029 (K MT)
Table 98. Biologics Market Opportunities & Trends in Global Market
Table 99. Biologics Market Drivers in Global Market
Table 100. Biologics Market Restraints in Global Market
Table 101. Biologics Raw Materials
Table 102. Biologics Raw Materials Suppliers in Global Market
Table 103. Typical Biologics Downstream
Table 104. Biologics Downstream Clients in Global Market
Table 105. Biologics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biologics Segment by Type in 2022
Figure 2. Biologics Segment by Application in 2022
Figure 3. Global Biologics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biologics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biologics Revenue, 2018-2029 (US$, Mn)
Figure 7. Biologics Sales in Global Market: 2018-2029 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Biologics Revenue in 2022
Figure 9. By Type - Global Biologics Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Biologics Revenue Market Share, 2018-2029
Figure 11. By Type - Global Biologics Sales Market Share, 2018-2029
Figure 12. By Type - Global Biologics Price (USD/MT), 2018-2029
Figure 13. By Application - Global Biologics Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Biologics Revenue Market Share, 2018-2029
Figure 15. By Application - Global Biologics Sales Market Share, 2018-2029
Figure 16. By Application - Global Biologics Price (USD/MT), 2018-2029
Figure 17. By Region - Global Biologics Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Biologics Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Biologics Revenue Market Share, 2018-2029
Figure 20. By Region - Global Biologics Sales Market Share, 2018-2029
Figure 21. By Country - North America Biologics Revenue Market Share, 2018-2029
Figure 22. By Country - North America Biologics Sales Market Share, 2018-2029
Figure 23. US Biologics Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Biologics Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Biologics Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Biologics Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Biologics Sales Market Share, 2018-2029
Figure 28. Germany Biologics Revenue, (US$, Mn), 2018-2029
Figure 29. France Biologics Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Biologics Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Biologics Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Biologics Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Biologics Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Biologics Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Biologics Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Biologics Sales Market Share, 2018-2029
Figure 37. China Biologics Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Biologics Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Biologics Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Biologics Revenue, (US$, Mn), 2018-2029
Figure 41. India Biologics Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Biologics Revenue Market Share, 2018-2029
Figure 43. By Country - South America Biologics Sales Market Share, 2018-2029
Figure 44. Brazil Biologics Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Biologics Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Biologics Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Biologics Sales Market Share, 2018-2029
Figure 48. Turkey Biologics Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Biologics Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Biologics Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Biologics Revenue, (US$, Mn), 2018-2029
Figure 52. Global Biologics Production Capacity (K MT), 2018-2029
Figure 53. The Percentage of Production Biologics by Region, 2022 VS 2029
Figure 54. Biologics Industry Value Chain
Figure 55. Marketing Channels
  • Global Nucleotide Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 132
    Nucleotides are organic molecules consisting of a nucleoside and a phosphate. They serve as monomeric units of the nucleic acid polymers deoxyribonucleic acid and ribonucleic acid, both of which are essential biomolecules within all life-forms on Earth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This wa......
  • Global Nucleotide Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 165
    Nucleotides are organic molecules consisting of a nucleoside and a phosphate. They serve as monomeric units of the nucleic acid polymers deoxyribonucleic acid and ribonucleic acid, both of which are essential biomolecules within all life-forms on Earth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This wa......
  • Global Bioburden Testing Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 120
    Report Overview: The Global Bioburden Testing Market Size was estimated at USD 898.90 million in 2022 and is projected to reach USD 1443.44 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Bioburden Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market dri......
  • Global qPCR Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global qPCR market: According to our latest research, the global qPCR market looks promising in the next 5 years. As of 2022, the global qPCR market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global qPCR market, with a systematical description of the status ......
  • Global Interferon Market Research Report 2023, Forecast to 2028
    Published: 01-Nov-2023        Price: US 2680 Onwards        Pages: 131
    Interferons are proteins that are part of your natural defenses. They tell your immune system that germs or cancer cells are in your body. And they trigger killer immune cells to fight those invaders. Interferons got their name because they "interfere" with viruses and keep them from multiplying. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Global Interferon Professional Survey Report 2023, Forecast to 2028
    Published: 01-Nov-2023        Price: US 3280 Onwards        Pages: 107
    Interferons are proteins that are part of your natural defenses. They tell your immune system that germs or cancer cells are in your body. And they trigger killer immune cells to fight those invaders. Interferons got their name because they "interfere" with viruses and keep them from multiplying. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Global Biologics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Oct-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Biologics market: According to our latest research, the global Biologics market looks promising in the next 5 years. As of 2022, the global Biologics market was estimated at USD 251622.83 million, and it's anticipated to reach USD 363588.32 million in 2028, with a CAGR of 6.33% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biologics market, with a sys......
  • Global Nucleotide Market Insights, Forecast to 2029
    Published: 25-Sep-2023        Price: US 4900 Onwards        Pages: 89
    Nucleotides are small organic molecules composed of purine bases or pyrimidine bases, pentoses and phosphoric acid. They are the structural units of nucleic acids, and their derivatives have a variety of biological functions. It can be used in the fields of food, pharmaceuticals and feed additive. The global Nucleotide market is projected to grow from US$ 511.1 million in 2023 to US$ 492.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of -0.6% during the forecast period. ......
  • 2023-2031 Report on Global Nucleotide Market by Player, Region, Type, Application and Sales Channel
    Published: 04-Sep-2023        Price: US 2500 Onwards        Pages: 89
    This report studies the Nucleotide market, covering market size for segment by type (Food Grade Nucleotide, Lab Grade Nucleotide, etc.), by application (Pharmaceuticals, Food & Beverage Additives, etc.), by sales channel (Direct Channel, Distribution Channel), by player (AJINOMOTO, CJ, DAESANG, Meihua Group, Star Lake Bioscience, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of g......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs